Intellikine LLC

Leland Stanford Junior University

Sun Pharma Advanced Research Company Limited

Khloris Biosciences, Inc.

Lynne Bui

Yi Liu

Troy Edward Wilson

Christian Rommel

Michael Martin

Subhas Balaram Bhowmick

Ajay Khopade

Joseph C Wu

Natarajan Arulsudar

Narendra Lakkad

Wen Wee Ma

Nigel G Kooreman

Alex Adjei

Ronald Harning

A method of treating patients suffering from carcinoma of intrahepatic or extra hepatic bile duct or gall bladder which is locally advanced or metastatic, by intravenously administering to the patient, paclitaxel in the form of a nanodispersion. The nanodispersion comprises particles with a mean particle size less than 300 nm and is free of polyoxyethylated castor oil and free of a protein.

Method of treating carcinoma

In one embodiment, the application discloses a method for the treatment of cancer in a patient, the method comprises a vaccination of the patient with a vaccine, wherein the vaccine comprises an effective amount of mammalian pluripotent stem cells obtained from an embryonic source or obtained by reprogramming of somatic cells from the patient, wherein the vaccination comprising the step of administering a mammalian pluripotent stem cells to the patient in need thereof; and vaccine formulations for use in the treatment of cancer.

IPSC-based vaccine as a prophylactic and therapeutic treatment for cancer

The present invention provides for methods and pharmaceutical compositions comprising inhibitors of mTorC1 and/or mTorC2. In some aspects, the invention provides for treatment regimens resulting in enhanced treatment efficacy and better tolerability.

Enhanced treatment regimens using mTOR inhibitors

Enhanced treatment regimens using mTor inhibitors

Growing community of inventors

Saratoga, CA, United States of America

Lynne Bui